Search research articles
Contact Us
Filters
Showing results (1-10 of 93) with videos related to
Page
of 10
Sort By:
British Journal of Cancer
|
April 5, 2022
Response to A. Chauhan and A. Pal
Alexios Matikas, Vassilis Georgoulias
Future Oncology (London, England)
|
March 12, 2015
Beyond CTLA-4: novel immunotherapy strategies for metastatic melanoma
Alexios Matikas, Dimitrios Mavroudis
Acta Obstetricia Et Gynecologica Scandinavica
|
November 20, 2023
Breast cancer during pregnancy-The oncologist's point of view
Alexios Matikas, Jonas Bergh
Expert Opinion on Emerging Drugs
|
May 4, 2016
Emerging agents for the prevention of treatment induced neutropenia in adult cancer patients
Alexios Matikas, Vassilis Georgoulias, Athanasios Kotsakis
Molecular Oncology
|
March 9, 2023
The interplay between eosinophils and T cells in breast cancer immunotherapy
Ioannis Zerdes, Alexios Matikas, Theodoros Foukakis
Acta Oncologica (Stockholm, Sweden)
|
May 25, 2017
Dose intense, dose dense and tailored dose adjuvant chemotherapy for early breast cancer: an evolution of concepts
Alexios Matikas, Theodoros Foukakis, Jonas Bergh
Journal of the National Cancer Institute
|
April 5, 2018
RE: Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis
Alexios Matikas, Theodoros Foukakis, Jonas Bergh
Clinical Lung Cancer
|
July 5, 2016
Circulating Biomarkers in Non-Small-Cell Lung Cancer: Current Status and Future Challenges
Alexios Matikas, Konstantinos N Syrigos, Sofia Agelaki
World Journal of Gastrointestinal Oncology
|
December 31, 2016
Role of circulating free DNA in colorectal cancer
Alexios Matikas, Alexandra Voutsina, Maria Trypaki, et al.
Drug Discovery Today
|
November 25, 2024
Breakthrough in RAS targeting with pan-RAS(ON) inhibitors RMC-7977 and RMC-6236
Panagiotis Filis, Dimitrios Salgkamis, Alexios Matikas, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 93) with videos related to
Sort By:
Page
of 10
British Journal of Cancer
|
April 5, 2022
Response to A. Chauhan and A. Pal
Alexios Matikas, Vassilis Georgoulias
Future Oncology (London, England)
|
March 12, 2015
Beyond CTLA-4: novel immunotherapy strategies for metastatic melanoma
Alexios Matikas, Dimitrios Mavroudis
Acta Obstetricia Et Gynecologica Scandinavica
|
November 20, 2023
Breast cancer during pregnancy-The oncologist's point of view
Alexios Matikas, Jonas Bergh
Expert Opinion on Emerging Drugs
|
May 4, 2016
Emerging agents for the prevention of treatment induced neutropenia in adult cancer patients
Alexios Matikas, Vassilis Georgoulias, Athanasios Kotsakis
Molecular Oncology
|
March 9, 2023
The interplay between eosinophils and T cells in breast cancer immunotherapy
Ioannis Zerdes, Alexios Matikas, Theodoros Foukakis
Acta Oncologica (Stockholm, Sweden)
|
May 25, 2017
Dose intense, dose dense and tailored dose adjuvant chemotherapy for early breast cancer: an evolution of concepts
Alexios Matikas, Theodoros Foukakis, Jonas Bergh
Journal of the National Cancer Institute
|
April 5, 2018
RE: Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis
Alexios Matikas, Theodoros Foukakis, Jonas Bergh
Clinical Lung Cancer
|
July 5, 2016
Circulating Biomarkers in Non-Small-Cell Lung Cancer: Current Status and Future Challenges
Alexios Matikas, Konstantinos N Syrigos, Sofia Agelaki
World Journal of Gastrointestinal Oncology
|
December 31, 2016
Role of circulating free DNA in colorectal cancer
Alexios Matikas, Alexandra Voutsina, Maria Trypaki, et al.
Drug Discovery Today
|
November 25, 2024
Breakthrough in RAS targeting with pan-RAS(ON) inhibitors RMC-7977 and RMC-6236
Panagiotis Filis, Dimitrios Salgkamis, Alexios Matikas, et al.
Page
of 10